A study of 802 adults transplanted for acute lymphoblastic leukemia (ALL) in first or second complete remission has found comparable outcomes using three different unrelated donor graft sources: mismatched single or double cord blood (CB; n=116), peripheral blood progenitor cells (PBPC; n=546), and bone marrow (BM; n=140). Recipients were similar except CB recipients were younger, more likely to be non-white, and to have low white blood cell count at diagnosis. Three-year survival was comparable among patients receiving CB (44%), matched (44%) and mismatched (43%) adult donor transplants (BM or PBPC).
Choose a Topic
- All Topics
- Patient Eligibility
- AML
- Unrelated Donor HCT
- Post-Transplant
- CIBMTR Publications
- GVHD
- ALL
- Lymphomas and CLL
- Preparative Regimens
- Pediatric HCT
- Older Patient HCT
- MDS
- Non-Malignant Disorders
- BMT CTN Publications
- Cord Blood
- Multiple Myeloma
- Sickle Cell Disease
- HLA Matching
- ASH 2015
- ASH 2017
- ASH 2016
- ASH 2020
- CML
- ASH 2018
- Neuroblastoma
Comparable Survival in Cord Blood and Adult Donor HCT for ALL
Oct 2013